Home » FDA Approves Labeling Update for HIV Drug
FDA Approves Labeling Update for HIV Drug
Bristol-Myers Squibb Company announced that the FDA has approved a labeling update for REYATAZ to include long-term data from the CASTLE Study.
Earth Times
Earth Times
Upcoming Events
-
07May
-
14May
-
30May